Shortages in medications have become common place, however we are now dealing with a shortage of diluents such as sterile water, dextrose and normal saline. This podcast episode discusses alternatives and conservation methods needed to combat these shortages.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHPOfficial

Shortages That Don’t Dilute: Alternatives to Diluent Shortages

This podcast episode offers insight on clinician burnout from a physician expert and senior advisor to the office of the Surgeon General. In an over-regulated industry and a work harder culture, how can we simplify our work lives to achieve well-being among leadership and staff. Well-being priorities from the office of the Surgeon General are discussed including components of an ideal healing healthcare system.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Insight on Clinician Burnout from the Senior Advisor to the Office of the Surgeon General

In this educator essentials podcast episode, we speak with Dr. Kelly Gable and Dr. Suzanne Harris about their unique academic leadership roles as directors of well-being and resilience within their institutions. This episode explores their career journeys, role innovations, and the importance of prioritizing the well-being of the pharmacy workforce through formal leadership.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Well-Being Leaders in Academia

This discussion is meant to be informative for pharmacists who are less familiar with immunotherapy-related adverse events, as well as to offer insight into decision making in challenging situations related to managing irAEs.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

irAE Potpourri: A Little Bit of This and That for Anyone and Everyone

Management of heart failure (HF) has evolved over the past few years, prompting the American College of Cardiology (ACC) to release a 2021 Update to Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment to provide guidance and recommendations on clinical care of HF patients with a reduced ejection fraction (HFrEF). New therapies for HFrEF have emerged that expand the arsenal for this patient population, particularly angiotensin receptor-neprilysin inhibitors (ARNI) and sodium glucose cotransporter-2 (SGLT2) inhibitors. However, use of guideline directed medical therapy (GDMT) is still suboptimal, and there is a need for pharmacists to assist in improving medication adherence. This podcast episode provides general practitioners an update on new evidence for pharmacotherapy and provides guidance on how to initiate GDMT in patients with HFrEF successfully in both inpatient and outpatient settings.      The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Expert Consensus Decision Pathway for Heart Failure with Reduced Ejection Fraction: Implications for Transitions of Care

During this podcast episode, we talk with two pharmacy-based social media influencers. We hope that through learning about their experiences, students may gain insight into how to leverage these platforms for their own professional development.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Social Media Do’s and Don’ts for Students

Learn from experts in the field on strategies for preventing controlled substances diversion and associated risk. Topics include waste minimization, controlled substance prevention program value proposition and position justification, auditing best practices, and creating an efficient – yet compliant – OR throughput.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Controlled Substances Diversion: Creating a Value Proposition for All

In this episode, Vicki Basalyga sits down with Katelyn Dervay, who relays how her time and training as an Emergency Medicine Pharmacist and experience on medical missions in Haiti translates to caring for patients as a Civilian Inpatient Pharmacist at Landstuhl Regional Medical Center. Katelyn shares what shaped her career, what she has learned along the way and how she integrated what she was passionate about into an exciting and dynamic pharmacy career.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Conversation with Katelyn Dervay

In this feature from the 2021 Specialty Pharmacy Conference, It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss key strategies to improve payer access and financial management of specialty pharmacy operations.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits

In this feature from the 2021 Specialty Pharmacy Conference: Managing Biosimilars: A Specialty All Its Own, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss strategies to evaluate and optimize biosimilars in your health-system and specialty practice.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Managing Biosimilars: A Specialty All Its Own

In this podcast episode, our content matter expert discusses what makes the recently published clinical practice guideline for the diagnosis and treatment of acute hematogenous osteomyelitis (AHO) in children unique and shares recommendations that could be practice changing at many facilities.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

What you might have missed in 2021: Highlights from the New Clinical Practice Guideline for Management of Pediatric Patients with Acute Hematogenous Osteomyelitis

Drs. Joseph DiPiro, Binita Patel, and Francesca Cunningham discuss the 2022 ASHP/ASHP Foundation Pharmacy Forecast Report, from its development to its impact, with host and AJHP Editor in Chief Daniel Cobaugh.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

2022 ASHP/ASHP Foundation Pharmacy Forecast

This podcast episode identifies what urine drug screens (UDS) can and cannot reveal and discusses different UDS results that may be available in your institution. Speakers will also touch on common misinterpretations when reviewing UDS screening results.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Become a Wiz at Urine Drug Screens (UDS)

Learn about implementation of ISMP targeted medication safety best practices for hospital #7 that states to segregate, sequester, and differentiate all neuromuscular blocking agents (NMBs) from other medications, wherever they are stored in the organization. Faculty will provide tips on implementing this best practice and how to ‘”hardwire” this into health system practices. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ISMP Targeted Medication Safety Best Practices for Hospitals #7 - neuromuscular blocking agents (NMB)

In this podcast we discuss with Dr. Andrea Luebchow, Program  Director II of Community Pharmacy Services at Atrium Health Wake Forest Baptist. Dr. Luebchow discusses her current role, responsibilities, as well as her leadership journey from retail to health-systems community pharmacy practice.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.  

Community Pharmacy: The Path to Leadership

ASHPOfficial is the premier podcast of ASHP and the collective voice of our 50,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.

hubhopper

ASHPOfficial

hubhopper